On Thursday, Shares of Citigroup Inc. (NYSE:C), gained 0.37% to $51.07.
Citigroup sent details of its central bank customers’ trading activity to another client and handed out details of its foreign exchange order book to customers in electronic chatrooms, a former foreign exchange trader said in a witness statement to a London court on Thursday, according to Reuters.
Perry Stimpson, a former Citigroup currency trader who is claiming unfair dismissal, said the practices, which breached client confidentiality, were well known by senior managers. Reuters Reports
“Our Investor Desk would comply with a weekly request from (a client) for details of Central Bank activity that Citi had transacted,” Stimpson said in his witness statement to an employment tribunal in London. Stimpson did not specify which central banks he was referring to.
He said Jeff Feig, who was Citi’s global head of trading at the time, called a halt to sending round the “central bank survey”, as Stimpson said it was referred to, in mid-2013 because he decided it was wrong. He did not elaborate.
Citigroup Inc., a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions worldwide. The company operates through two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG).
Shares of WPX Energy, Inc. (NYSE:WPX), inclined 5.90% to $7.90, during its last trading session, as stocks within the energy sector tick higher together with the price of oil.
U.S. oil companies produced an average of 9.14 million barrels per day for the week ended September 4, this is a decline from the 9.22 million barrels per day from the previous week, Reuters reports.
Additionally, U.S. commercial crude stockpiles grew by 2.6 million barrels, Reuters added. This brings the total to 458 million barrels, close to an 80-year high.
WPX Energy, Inc., an independent natural gas and oil exploration and production company, engages in the exploitation and development of unconventional properties in the United States.
Finally, ZS Pharma, Inc. (NASDAQ:ZSPH), ended its last trade with 28.42% gain, and closed at $74.73, hitting its highest level.
ZS Pharma, confirmed that it has taken part in preliminary negotiations with Actelion Ltd. (ALIOF) regarding a potential planned transaction. ZS Pharma regularly and routinely explores opportunities with various planned partners and will continue to do so. These negotiations may or may not lead to any transaction. ZS Pharma does not intend to comment further on market speculation or disclose any developments unless and until it otherwise deems further disclosure is appropriate or required.
ZS Pharma, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver, and metabolic diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
